Organization "North American Association of Central Cancer Registries (NAACCR) " information

Address:
2121 West White Oaks Drive
Suite B
Springfield, IL 62704-7412
United States (the)
Phone:
+1 217 698 0800
Email:
info@naaccr.org

First registered objects (87)

OIDNameDescription
2.16.840.1.113883.3.520.1.48 patient-referred-to
2.16.840.1.113883.3.520.3.7 tnm-clinical-n
2.16.840.1.113883.3.520.2.6 cancer-course-of-treatment
2.16.840.1.113883.3.520.1.10 behavior
2.16.840.1.113883.3.520.1.30 text-diagnostic-procedure-scopes
2.16.840.1.113883.3.520.1.17 hospital-name
2.16.840.1.113883.3.520.2.7 patient-status
2.16.840.1.113883.3.520.1.5 tnm-clinical-t
2.16.840.1.113883.3.520.2.5 supporting-documentation
2.16.840.1.113883.3.520.1.14 diagnosing-laboratory-name
2.16.840.1.113883.3.520.1.31 text-diagnostic-procedure-lab-tests
2.16.840.1.113883.3.520.3.13 screening-result
2.16.840.1.113883.3.520.2.1 social-history
2.16.840.1.113883.3.520.3.15 grade
2.16.840.1.113883.3.520.4.16 naaccr-icd-9-cm-cancer-reportability-list
2.16.840.1.113883.3.520.3.12 quality-of-survival
2.16.840.1.113883.3.520.3.14 behavior-code
2.16.840.1.113883.3.520.4.8 naaccr-tnm-clinical-m
2.16.840.1.113883.3.520.1.1 laterality
2.16.840.1.113883.3.520.1.11 grade
2.16.840.1.113883.3.520.1.12 diagnostic-confirmation
2.16.840.1.113883.3.520.1.13 cancer-status
2.16.840.1.113883.3.520.1.15 quality-of-survival
2.16.840.1.113883.3.520.1.16 hospitalization-status
2.16.840.1.113883.3.520.1.18 radiation-therapy-facility
2.16.840.1.113883.3.520.1.19 screening-result
2.16.840.1.113883.3.520.1.2 histology
2.16.840.1.113883.3.520.1.20 diagnosis-observation
2.16.840.1.113883.3.520.1.21 primary-site
2.16.840.1.113883.3.520.1.22 occupation
2.16.840.1.113883.3.520.1.23 industry
2.16.840.1.113883.3.520.1.24 provider-referred-from
2.16.840.1.113883.3.520.1.25 cause-of-death
2.16.840.1.113883.3.520.1.26 place-of-death
2.16.840.1.113883.3.520.1.27 text-place-of-diagnosis
2.16.840.1.113883.3.520.1.28 text-diagnostic-procedure-physical-exam
2.16.840.1.113883.3.520.1.29 text-diagnostic-procedure-x-ray-scan
2.16.840.1.113883.3.520.1.3 tnm-edition
2.16.840.1.113883.3.520.1.32 text-diagnostic-procedure-operation
2.16.840.1.113883.3.520.1.33 text-diagnostic-procedure-pathology
2.16.840.1.113883.3.520.1.34 text-diagnostic-procedure-prognostic-factors
2.16.840.1.113883.3.520.1.36 chemotherapy
2.16.840.1.113883.3.520.1.37 chemotherapy-protocol-regimen-text
2.16.840.1.113883.3.520.1.38 drug-names
2.16.840.1.113883.3.520.1.39 hormone-therapy
2.16.840.1.113883.3.520.1.4 tnm-clinical-staged-by
2.16.840.1.113883.3.520.1.40 immunotherapy-brm
2.16.840.1.113883.3.520.1.41 other-therapy
2.16.840.1.113883.3.520.1.42 hematological-transplant-or-endrine-procedure-text
2.16.840.1.113883.3.520.1.43 palliative-care
2.16.840.1.113883.3.520.1.44 recurrent-location
2.16.840.1.113883.3.520.1.45 cormorbidities
2.16.840.1.113883.3.520.1.46 payer-history
2.16.840.1.113883.3.520.1.47 histology-organiser
2.16.840.1.113883.3.520.1.6 tnm-clinical-n
2.16.840.1.113883.3.520.1.7 tnm-clinical-m
2.16.840.1.113883.3.520.1.8 tnm-clinical-stage-group
2.16.840.1.113883.3.520.1.9 tnm-clinical-stage-descriptor
2.16.840.1.113883.3.520.4.9 naaccr-tnm-clinical-stage-group
2.16.840.1.113883.3.520.4.13 naaccr-screening-result
2.16.840.1.113883.3.520.2.8 cancer-control
2.16.840.1.113883.3.520.2.3 diagnosis
2.16.840.1.113883.3.520.3.16 history-of-tobacco-use
2.16.840.1.113883.3.520.2.9 cancer-treatment-plan
2.16.840.1.113883.3.520.4.6 naaccr-tnm-clinical-t
2.16.840.1.113883.3.520.2.2 payers
2.16.840.1.113883.3.520.4.7 naaccr-tnm-clinical-n
2.16.840.1.113883.3.520.4.15 naaccr-grade
2.16.840.1.113883.3.520.3.4 tnm-clincal-staged-by
2.16.840.1.113883.3.520.3.6 tnm-clinical-t
2.16.840.1.113883.3.520.4.1 naaccr-laterality
2.16.840.1.113883.3.520.4.10 naaccr-tnm-clinical-stage-descriptor
2.16.840.1.113883.3.520.4.11 naaccr-cancer-status
2.16.840.1.113883.3.520.4.12 naaccr-quality-of-survival
2.16.840.1.113883.3.520.4.14 naaccr-behavior-code
2.16.840.1.113883.3.520.4.2 naaccr-histology
2.16.840.1.113883.3.520.4.3 naaccr-diagnostic-confirmation
2.16.840.1.113883.3.520.4.4 naaccr-tnm-clinical-staged-by
2.16.840.1.113883.3.520.4.5 naaccr-tnm-edition-number
2.16.840.1.113883.3.520.3.11 cancer-status
2.16.840.1.113883.3.520.3.8 tnm-clinical-m
2.16.840.1.113883.3.520.3.1 laterality
2.16.840.1.113883.3.520.3.10 tnm-clinical-stage-descriptor
2.16.840.1.113883.3.520.3.2 histology
2.16.840.1.113883.3.520.3.3 naaccr-diagnostic-confirmation
2.16.840.1.113883.3.520.3.5 tnm-edition-number
2.16.840.1.113883.3.520.3.9 tnm-clinical-stage-group